-
Signature
-
/s/ John Ferrantino, Attorney-in-fact
-
Issuer symbol
-
TBLA
-
Transactions as of
-
19 Dec 2023
-
Net transactions value
-
-$152,734
-
Form type
-
4
-
Filing time
-
21 Dec 2023, 16:33:13 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TBLA |
Ordinary Shares |
Options Exercise |
$27,300 |
+30,000 |
+1.2% |
$0.9100 |
2,575,291 |
19 Dec 2023 |
Direct |
|
| transaction |
TBLA |
Ordinary Shares |
Sale |
$115,500 |
-30,000 |
-1.2% |
$3.85 |
2,545,291 |
19 Dec 2023 |
Direct |
F1, F2 |
| transaction |
TBLA |
Ordinary Shares |
Options Exercise |
$19,446 |
+21,369 |
+0.84% |
$0.9100 |
2,566,660 |
20 Dec 2023 |
Direct |
|
| transaction |
TBLA |
Ordinary Shares |
Sale |
$83,980 |
-21,369 |
-0.83% |
$3.93 |
2,545,291 |
20 Dec 2023 |
Direct |
F1, F3, F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
TBLA |
Share Option (Right to Buy) |
Options Exercise |
$0 |
-30,000 |
-4.8% |
$0.000000 |
596,088 |
19 Dec 2023 |
Ordinary Shares |
30,000 |
$0.9100 |
Direct |
F6 |
| transaction |
TBLA |
Share Option (Right to Buy) |
Options Exercise |
$0 |
-21,369 |
-3.6% |
$0.000000 |
574,719 |
20 Dec 2023 |
Ordinary Shares |
21,369 |
$0.9100 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: